XFOR icon

X4 Pharmaceuticals

56 hedge funds and large institutions have $58.3M invested in X4 Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

0.16% more ownership

Funds ownership: 1.74%1.9% (+0.16%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

44% less call options, than puts

Call options by funds: $123K | Put options by funds: $221K

Holders
56
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$123K
Puts
$221K
Net Calls
Net Calls Change

Top Buyers

1 +$11.2M
2 +$5.76M
3 +$5.09M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.26M
5
SCM
Sio Capital Management
New York
+$1.95M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$11.2M
2
$10.9M
3
$7.06M
4
$5.49M
5
$4.35M
6
$4.28M
7
$2.43M
8
$1.71M
9
$1.63M
10
$1.45M
11
$1.42M
12
$973K
13
$844K
14
$573K
15
$532K
16
$494K
17
$428K
18
$414K
19
$258K
20
$239K
21
$193K
22
$146K
23
$115K
24
$103K
25
$101K